Prices of weight-loss drugs set to halve in India as Ozempic patent expires this week
Swati Pradhan sees about 12 obesity patients a day at her small clinic in southern Mumbai. She expects this number to at least double from this month as Indian drugmakers prepare to launch generic versions of Novo Nordisk's blockbuster weight-loss drug …